Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
16 studies found for:    "Flibanserin"
Show Display Options
Rank Status Study
1 Completed
Has Results
24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
Condition: Sexual Dysfunctions, Psychological
Intervention: Drug: flibanserin
2 Recruiting Effects of Flibanserin on the Pre- and Post-menopausal Female Brain
Condition: Hypoactive Sexual Desire Disorder
Interventions: Drug: Flibanserin;   Drug: Placebo
3 Recruiting Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
Condition: Hypoactive Sexual Desire Disorder
Interventions: Behavioral: sex therapy;   Drug: flibanserin
4 Completed
Has Results
Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder
Condition: Sexual Dysfunctions, Psychological
Intervention: Drug: flibanserin flexible dose
5 Completed
Has Results
Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)
Condition: Sexual Dysfunctions, Psychological
Intervention: Drug: flibanserin 100 mg dose every evening
6 Terminated
Has Results
A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder
Condition: Sexual Dysfunctions, Psychological
Intervention: Drug: flibanserin
7 Completed
Has Results
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
Condition: Sexual Dysfunctions, Psychological
Interventions: Drug: flibanserin;   Drug: placebo
8 Completed
Has Results
Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
Condition: Sexual Dysfunctions, Psychological
Interventions: Drug: Flibanserin;   Drug: Placebo
9 Terminated
Has Results
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America
Condition: Sexual Dysfunctions, Psychological
Interventions: Drug: Flibanserin;   Drug: Placebo
10 Terminated
Has Results
A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).
Condition: Sexual Dysfunctions, Psychological
Intervention: Drug: Flibanserin
11 Completed Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
Condition: Sexual Dysfunctions, Psychological
Intervention: Drug: Flibanserin
12 Terminated
Has Results
12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress
Conditions: Sexual Dysfunctions, Psychological;   Depression
Interventions: Drug: flibanserin 50 mg to 100 mg qhs;   Drug: flibanserin 100 mg qhs;   Drug: placebo 2 tablets qhs
13 Completed to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy Volunteers
Condition: Healthy
Interventions: Drug: Flibanserin plus Digoxin;   Drug: Digoxin
14 Completed
Has Results
6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
Condition: Sexual Dysfunctions, Psychological
Interventions: Drug: flibanserin;   Drug: placebo
15 Completed
Has Results
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
Condition: Sexual Dysfunctions, Psychological
Interventions: Drug: flibanserin;   Drug: flibanserin 50mg;   Drug: flibanserin 100mg;   Drug: placebo
16 Completed
Has Results
Flibanserin Versus Placebo in Premenopausal Women With HSDD
Condition: Sexual Dysfunctions, Psychological
Interventions: Drug: 50 mg qhs;   Drug: 100 mg;   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.